Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogen Peroxide | 3 | 2025 | 193 | 0.970 |
Why?
|
| Water Pollutants, Chemical | 4 | 2014 | 170 | 0.860 |
Why?
|
| Cell Movement | 1 | 2025 | 640 | 0.700 |
Why?
|
| Nanoparticles | 4 | 2014 | 449 | 0.680 |
Why?
|
| Artemia | 4 | 2014 | 13 | 0.670 |
Why?
|
| MicroRNAs | 1 | 2025 | 501 | 0.610 |
Why?
|
| Zinc Oxide | 2 | 2014 | 25 | 0.520 |
Why?
|
| Nigella sativa | 2 | 2005 | 2 | 0.440 |
Why?
|
| Goldfish | 1 | 2014 | 18 | 0.440 |
Why?
|
| Copper | 1 | 2014 | 134 | 0.390 |
Why?
|
| Titanium | 1 | 2012 | 46 | 0.370 |
Why?
|
| Cadmium | 2 | 2011 | 54 | 0.340 |
Why?
|
| Toluene | 2 | 2007 | 11 | 0.310 |
Why?
|
| Breast Neoplasms | 3 | 2005 | 1679 | 0.280 |
Why?
|
| Benzothiazoles | 2 | 2007 | 26 | 0.270 |
Why?
|
| Hepatoblastoma | 1 | 2007 | 3 | 0.260 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2014 | 1112 | 0.260 |
Why?
|
| Hepatocytes | 1 | 2007 | 79 | 0.250 |
Why?
|
| Energy Metabolism | 1 | 2007 | 181 | 0.240 |
Why?
|
| DNA Repair | 1 | 2007 | 196 | 0.230 |
Why?
|
| Parvoviridae Infections | 1 | 2025 | 2 | 0.230 |
Why?
|
| Parvovirus B19, Human | 1 | 2025 | 2 | 0.230 |
Why?
|
| Malondialdehyde | 3 | 2014 | 42 | 0.230 |
Why?
|
| Fibroblasts | 1 | 2007 | 278 | 0.230 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 228 | 0.230 |
Why?
|
| Arsenic | 1 | 2007 | 151 | 0.220 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 979 | 0.220 |
Why?
|
| Plant Extracts | 2 | 2005 | 303 | 0.200 |
Why?
|
| Diacetyl | 1 | 2003 | 2 | 0.200 |
Why?
|
| Salmonella typhimurium | 1 | 2003 | 40 | 0.200 |
Why?
|
| Anemia, Sickle Cell | 1 | 2025 | 185 | 0.190 |
Why?
|
| Pesticides | 1 | 2003 | 59 | 0.190 |
Why?
|
| Reactive Oxygen Species | 1 | 2025 | 518 | 0.190 |
Why?
|
| Hot Temperature | 1 | 2003 | 141 | 0.190 |
Why?
|
| Staphylococcus aureus | 1 | 2003 | 91 | 0.180 |
Why?
|
| Soil Pollutants | 1 | 2003 | 104 | 0.180 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 479 | 0.180 |
Why?
|
| Cell Survival | 4 | 2007 | 934 | 0.170 |
Why?
|
| Oxidative Stress | 5 | 2014 | 990 | 0.170 |
Why?
|
| Environmental Exposure | 1 | 2003 | 247 | 0.170 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2018 | 19 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2018 | 136 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 189 | 0.130 |
Why?
|
| Humans | 11 | 2025 | 42163 | 0.120 |
Why?
|
| Bioprosthesis | 2 | 2005 | 6 | 0.120 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2005 | 26 | 0.120 |
Why?
|
| Heart Valve Prosthesis | 2 | 2005 | 45 | 0.120 |
Why?
|
| Lethal Dose 50 | 2 | 2007 | 32 | 0.120 |
Why?
|
| Lipid Peroxidation | 2 | 2012 | 141 | 0.120 |
Why?
|
| Animals | 9 | 2014 | 16695 | 0.110 |
Why?
|
| Particle Size | 2 | 2013 | 267 | 0.110 |
Why?
|
| Cytoprotection | 2 | 2007 | 36 | 0.110 |
Why?
|
| Food Chain | 1 | 2014 | 20 | 0.110 |
Why?
|
| Liver | 2 | 2011 | 503 | 0.110 |
Why?
|
| Aluminum Oxide | 1 | 2013 | 11 | 0.110 |
Why?
|
| Tissue Distribution | 1 | 2014 | 230 | 0.100 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 2598 | 0.100 |
Why?
|
| Chordae Tendineae | 1 | 2011 | 1 | 0.090 |
Why?
|
| Rheumatic Heart Disease | 1 | 2011 | 4 | 0.090 |
Why?
|
| Cadmium Compounds | 1 | 2011 | 7 | 0.090 |
Why?
|
| Zinc | 1 | 2012 | 130 | 0.090 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 46 | 0.090 |
Why?
|
| Selenium Compounds | 1 | 2011 | 11 | 0.090 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2011 | 22 | 0.090 |
Why?
|
| Mitral Valve | 1 | 2011 | 37 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2011 | 54 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2007 | 1617 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2014 | 461 | 0.080 |
Why?
|
| Kidney | 1 | 2011 | 363 | 0.070 |
Why?
|
| Aortic Valve | 2 | 2005 | 38 | 0.070 |
Why?
|
| Rats, Wistar | 2 | 2007 | 282 | 0.070 |
Why?
|
| Rats | 5 | 2011 | 3701 | 0.070 |
Why?
|
| Metal Nanoparticles | 1 | 2011 | 227 | 0.070 |
Why?
|
| Cell Size | 1 | 2007 | 46 | 0.060 |
Why?
|
| Water | 2 | 2006 | 314 | 0.060 |
Why?
|
| Drug Combinations | 1 | 2007 | 102 | 0.060 |
Why?
|
| Mississippi | 2 | 2006 | 129 | 0.060 |
Why?
|
| Water Supply | 1 | 2006 | 59 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2011 | 1586 | 0.060 |
Why?
|
| Rivers | 1 | 2006 | 50 | 0.060 |
Why?
|
| Water Microbiology | 1 | 2006 | 82 | 0.060 |
Why?
|
| Reference Values | 2 | 2003 | 207 | 0.060 |
Why?
|
| Temperature | 2 | 2006 | 314 | 0.060 |
Why?
|
| Androstenedione | 2 | 2003 | 19 | 0.060 |
Why?
|
| Heart Valve Diseases | 1 | 2005 | 15 | 0.060 |
Why?
|
| Dihydrotestosterone | 2 | 2003 | 28 | 0.060 |
Why?
|
| Solvents | 1 | 2005 | 109 | 0.060 |
Why?
|
| Cell Line | 2 | 2007 | 1416 | 0.060 |
Why?
|
| Sudan | 1 | 2025 | 3 | 0.060 |
Why?
|
| Immunoglobulin M | 1 | 2025 | 87 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2007 | 233 | 0.050 |
Why?
|
| DNA Damage | 1 | 2007 | 358 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2007 | 211 | 0.050 |
Why?
|
| Testosterone | 2 | 2003 | 211 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2025 | 253 | 0.050 |
Why?
|
| Bacteria | 1 | 2006 | 285 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2025 | 456 | 0.050 |
Why?
|
| Ethanol | 1 | 2005 | 221 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2025 | 323 | 0.050 |
Why?
|
| Adenosarcoma | 1 | 2003 | 1 | 0.050 |
Why?
|
| Renal Artery | 1 | 2003 | 7 | 0.050 |
Why?
|
| Colony Count, Microbial | 1 | 2003 | 67 | 0.050 |
Why?
|
| Larva | 2 | 2013 | 131 | 0.050 |
Why?
|
| Cell Membrane Permeability | 1 | 2003 | 57 | 0.050 |
Why?
|
| Food Contamination | 1 | 2003 | 55 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2025 | 295 | 0.050 |
Why?
|
| Seeds | 1 | 2003 | 46 | 0.050 |
Why?
|
| Crops, Agricultural | 1 | 2003 | 36 | 0.050 |
Why?
|
| Female | 5 | 2025 | 24018 | 0.050 |
Why?
|
| Phytotherapy | 1 | 2003 | 78 | 0.050 |
Why?
|
| Male | 6 | 2025 | 22779 | 0.050 |
Why?
|
| Androgens | 1 | 2003 | 107 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 314 | 0.050 |
Why?
|
| Cadmium Chloride | 1 | 2002 | 10 | 0.050 |
Why?
|
| Aorta | 1 | 2003 | 197 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 506 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 1066 | 0.040 |
Why?
|
| Thiazoles | 1 | 2002 | 76 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 602 | 0.040 |
Why?
|
| Phylogeny | 1 | 2025 | 740 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 209 | 0.040 |
Why?
|
| Oxides | 1 | 2002 | 97 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2002 | 123 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2007 | 1420 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2025 | 1516 | 0.040 |
Why?
|
| Prevalence | 1 | 2025 | 1597 | 0.040 |
Why?
|
| Myocardium | 1 | 2002 | 251 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 1058 | 0.040 |
Why?
|
| Young Adult | 2 | 2025 | 4936 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2003 | 1221 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2018 | 64 | 0.040 |
Why?
|
| Cytokines | 1 | 2002 | 661 | 0.030 |
Why?
|
| Adult | 2 | 2025 | 13458 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2018 | 348 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2011 | 1737 | 0.030 |
Why?
|
| Child | 1 | 2025 | 3381 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 1051 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 973 | 0.030 |
Why?
|
| Hemodynamics | 2 | 2005 | 101 | 0.030 |
Why?
|
| Risk Factors | 1 | 2003 | 3942 | 0.030 |
Why?
|
| Ecotoxicology | 1 | 2013 | 10 | 0.030 |
Why?
|
| X-Ray Diffraction | 1 | 2013 | 66 | 0.030 |
Why?
|
| Adolescent | 1 | 2025 | 5950 | 0.030 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2013 | 82 | 0.030 |
Why?
|
| Seawater | 1 | 2013 | 53 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2011 | 23 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2011 | 103 | 0.020 |
Why?
|
| Apoptosis | 1 | 2018 | 1541 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 845 | 0.020 |
Why?
|
| Filtration | 1 | 2006 | 17 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2006 | 55 | 0.020 |
Why?
|
| Quality Control | 1 | 2006 | 41 | 0.020 |
Why?
|
| Recreation | 1 | 2006 | 42 | 0.020 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2005 | 3 | 0.020 |
Why?
|
| Reoperation | 1 | 2005 | 31 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2005 | 48 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2006 | 385 | 0.010 |
Why?
|
| Oxygen | 1 | 2006 | 217 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 2005 | 47 | 0.010 |
Why?
|
| Environmental Monitoring | 1 | 2006 | 226 | 0.010 |
Why?
|
| Echocardiography | 1 | 2005 | 167 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2005 | 362 | 0.010 |
Why?
|
| Drug Implants | 1 | 2003 | 20 | 0.010 |
Why?
|
| Calcium Phosphates | 1 | 2003 | 15 | 0.010 |
Why?
|
| Aged | 2 | 2005 | 7982 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2002 | 39 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2002 | 165 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2005 | 1574 | 0.010 |
Why?
|
| Arsenicals | 1 | 2002 | 87 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2002 | 487 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2003 | 273 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 379 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 2803 | 0.010 |
Why?
|
| Middle Aged | 1 | 2005 | 11819 | 0.010 |
Why?
|